One-year moderate, vigorous exercise programs tied to reduction in 10-year risk for diabetes
WEDNESDAY, Feb. 1, 2023 (HealthDay News) — A 12-month vigorous or moderate aerobic exercise program can produce long-term beneficial effects on diabetes prevention in individuals with central obesity, according to a research letter published online Jan. 30 in JAMA Internal Medicine.
Ying Chen, M.D., Ph.D., from Fudan University in Shanghai, and colleagues assessed the long-term effect of a 12-month vigorous or moderate exercise intervention (coached and supervised) on incident diabetes during 10 years of follow-up. The analysis included participants with central obesity and nonalcoholic fatty liver disease who were randomly assigned to vigorous aerobic exercise (73 individuals), moderate aerobic exercise (73 individuals), or a nonexercise control group (74 individuals). Participants were asked not to change their diet.
The researchers observed no significant differences between the groups at 10-year follow-up, although there was a trend of higher levels of leisure-time physical activity in the exercise groups versus the control group. The risk for diabetes was lower in the vigorous aerobic exercise group (relative risk, 0.51) and in the moderate aerobic exercise group (relative risk, 0.47) versus the nonexercise group. Similarly, hemoglobin A1c and waist circumference were significantly reduced in the vigorous and moderate exercise groups versus the nonexercise group. Fasting plasma glucose level and weight regain trended lower in the exercise groups than the nonexercise group, although not significantly.
“Our results are supportive of physical exercise as an effective scheme for obesity management to delay the progression of type 2 diabetes,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Time-Restricted Eating May Help Patients With Type 1 Diabetes
Calorie Restriction and Mediterranean-Style Diet Yield Similar Weight Loss
Strength Training May Cut GDM Risk in Pregnant Women With Overweight, Obesity
Most Metabolic and Bariatric Surgery Candidates Meet Criteria for Clinical Obesity
Reinitiating Obesity Meds After Bariatric Surgery Tied to Greater One-Year Weight Loss in Youths
Obesity Treatment for U.S. Adolescents and Young Adults Shifted Rapidly From 2022 to 2026
3.2 Percent Undergoing Bariatric Surgery Develop New Alcohol-Related Diagnosis
RYGB, Sleeve Gastrectomy Cost-Effective for Teens With Severe Obesity